These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1450184)

  • 1. Increased lipid binding to thrombi in coronary artery disease. Findings in patients without premedication in native (not anticoagulated) test systems.
    Kunz F; Pechlaner C; Erhart R; Zwierzina WD; Kemmler G
    Arterioscler Thromb; 1992 Dec; 12(12):1516-21. PubMed ID: 1450184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL and plasma phospholipids in coronary artery disease.
    Kunz F; Pechlaner C; Erhart R; Fend F; Mühlberger V
    Arterioscler Thromb; 1994 Jul; 14(7):1146-50. PubMed ID: 8018671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid binding in blood clots in acute myocardial infarct].
    Kunz F; Hörtnagl H; Zwierzina WD; Geissler D
    Acta Med Austriaca; 1981; 8(5):133-9. PubMed ID: 7331740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clot lipids in ischaemic heart disease.
    Kunz F; Zwierzina WD; Hörtnagl H
    Atherosclerosis; 1983 Nov; 49(2):195-202. PubMed ID: 6667281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma fibrinogen in coronary arterial disease: marker or causative risk factor for arterial thrombosis?
    Kovacs IB; Ratnatunga CP; Ridler CD; Görög P; Edmondson SJ; Rees GM
    Int J Cardiol; 1992 Apr; 35(1):57-64. PubMed ID: 1563880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.
    Owaynat H; Yermolenko IS; Turaga R; Lishko VK; Sheller MR; Ugarova TP
    Thromb Res; 2015 Dec; 136(6):1231-9. PubMed ID: 26482763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function and composition in heart transplant recipients compared with nontransplanted coronary patients.
    de Lorgeril M; Dureau G; Boissonnat P; Guidollet J; Juhan-Vague I; Bizollon C; Renaud S
    Arterioscler Thromb; 1992 Feb; 12(2):222-30. PubMed ID: 1543695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against hypercoagulability in coronary artery disease.
    Görög P; Ridler CD; Rees GM; Kovacs IB
    Thromb Res; 1995 Aug; 79(4):377-85. PubMed ID: 7482441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.
    Eitzman DT; Chi L; Saggin L; Schwartz RS; Lucchesi BR; Fay WP
    Circulation; 1994 Apr; 89(4):1523-9. PubMed ID: 8149517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway.
    Boberg M; Croon LB; Gustafsson IB; Vessby B
    Clin Sci (Lond); 1985 May; 68(5):581-7. PubMed ID: 3919990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructure and composition of thrombi in coronary and peripheral artery disease: correlations with clinical and laboratory findings.
    Kovács A; Sótonyi P; Nagy AI; Tenekedjiev K; Wohner N; Komorowicz E; Kovács E; Nikolova N; Szabó L; Kovalszky I; Machovich R; Szelid Z; Becker D; Merkely B; Kolev K
    Thromb Res; 2015 Apr; 135(4):760-6. PubMed ID: 25686880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi.
    Fay WP; Murphy JG; Owen WG
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1277-84. PubMed ID: 8857925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulant activities of platelets in coronary artery disease.
    Rao AK; Mintz PD; Lavine SJ; Bove AA; McDonough MT; Spann JF; Walsh PN
    Circulation; 1984 Jan; 69(1):15-21. PubMed ID: 6689640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid composition of platelets and of plasma lipid esters in relation to platelet function in patients with ischaemic heart disease.
    Boberg M; Vessby B; Croon LB
    Atherosclerosis; 1985 Dec; 58(1-3):49-63. PubMed ID: 2936356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for coronary heart disease and platelet functions.
    Renaud S
    Adv Exp Med Biol; 1984; 164():129-44. PubMed ID: 6695570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
    Nofer JR; Brodde MF; Kehrel BE
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):726-35. PubMed ID: 20337657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation by activated platelets: a possible link between thrombosis and atherogenesis.
    Gorog P; Kovacs IB
    Atherosclerosis; 1995 May; 115(1):121-8. PubMed ID: 7669082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.